Austin Crinklaw

Austin Crinklaw

Auto-generated profile, based on publicly available information

Austin Crinklaw

Jumpcode Genomics, San Diego, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
AMAlessandro Montemurro
Alessandro Montemurro
VSViktoria Schuster
Viktoria Schuster
HPHelle Rus Povlsen
Helle Rus Povlsen
ABAmalie Kai Bentzen
Amalie Kai Bentzen
VJVanessa Jurtz
Vanessa Jurtz
MNMorten Nielsen
Morten Nielsen
Prediction of T-cell receptor (TCR) interactions with MHC-peptide complexes remains highly challenging. This challenge is primarily due to three dominant factors: data accuracy, data scarceness, and problem complexity. Here, we showcase that “shallow” convolutional neural network (CNN) architectures are adequate to deal with the problem complexity imposed by the length variations of TCRs. We demonstrate that current public bulk CDR3β-pMHC binding data overall is of low quality and that the development of accurate prediction models is contingent on paired α/β TCR sequence data corresponding to at least 150 distinct pairs for each investigated pMHC. In comparison, models trained on CDR3α or CDR3β data alone demonstrated a variable and pMHC specific relative performance drop. Together these findings support that T-cell specificity is predictable given the availability of accurate and sufficient paired TCR sequence data. NetTCR-2.0 is publicly available at https://services.healthtech.dtu.dk/service.php?NetTCR-2.0.

21 December 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VCVivek Chandra
Vivek Chandra
SBSourya Bhattacharyya
Sourya Bhattacharyya
BSBenjamin J. Schmiedel
Benjamin J. Schmiedel
AMAriel Madrigal
Ariel Madrigal
CGCristian Gonzalez-Colin
Cristian Gonzalez-Colin
PVPandurangan Vijayanand
Pandurangan Vijayanand

30 June 2021 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
RTRashmi Tippalagama
Rashmi Tippalagama
ASAkul Singhania
Akul Singhania
PDPaige Dubelko
Paige Dubelko
CACecilia S. Lindestam Arlehamn
Cecilia S. Lindestam Arlehamn
ACAustin Crinklaw
Austin Crinklaw
JBJulie G. Burel
Julie G. Burel
Upon Ag encounter, T cells can rapidly divide and form an effector population, which plays an important role in fighting acute infections. In humans, little is known about the molecular markers that distinguish such effector cells from other T cell populations. To address this, we investigated the molecular profile of T cells present in individuals with active tuberculosis (ATB), where we expect Ag encounter and expansion of effector cells to occur at higher frequency in contrast to Mycobacterium tuberculosis–sensitized healthy IGRA+ individuals. We found that the frequency of HLA-DR+ cells was increased in circulating CD4 T cells of ATB patients, and was dominantly expressed in M. tuberculosis Ag–specific CD4 T cells. We tested and confirmed that HLA-DR is a marker of recently divided CD4 T cells upon M. tuberculosis Ag exposure using an in vitro model examining the response of resting memory T cells from healthy IGRA+ to Ags. Thus, HLA-DR marks a CD4 T cell population that can be directly detected ex vivo in human peripheral blood, whose frequency is increased during ATB disease and contains recently divided Ag-specific effector T cells. These findings will facilitate the monitoring and study of disease-specific effector T cell responses in the context of ATB and other infections.

19 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
APAmitabh C. Pandey
Amitabh C. Pandey
JBJon Bezney
Jon Bezney
DDDante DeAscanis
Dante DeAscanis
EKEthan B. Kirsch
Ethan B. Kirsch
FAFarin Ahmed
Farin Ahmed
ETEric J. Topol
Eric J. Topol
Single-cell RNA-seq (scRNAseq) struggles to capture the cellular heterogeneity of transcripts within individual cells due to the prevalence of highly abundant and ubiquitous transcripts, which can obscure the detection of biologically distinct transcripts expressed up to several orders of magnitude lower levels. To address this challenge, here we introduce single-cell CRISPRclean (scCLEAN), a molecular method that globally recomposes scRNAseq libraries, providing a benefit that cannot be recapitulated with deeper sequencing. scCLEAN utilizes the programmability of CRISPR/Cas9 to target and remove less than 1% of the transcriptome while redistributing approximately half of reads, shifting the focus toward less abundant transcripts. We experimentally apply scCLEAN to both heterogeneous immune cells and homogenous vascular smooth muscle cells to demonstrate its ability to uncover biological signatures in different biological contexts. We further emphasize scCLEAN’s versatility by applying it to a third-generation sequencing method, single-cell MAS-Seq, to increase transcript-level detection and discovery. Here we show the possible utility of scCLEAN across a wide array of human tissues and cell types, indicating which contexts this technology proves beneficial and those in which its application is not advisable.

11 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
WCWilliam D. Chronister
William D. Chronister
ACAustin Crinklaw
Austin Crinklaw
SMSwapnil Mahajan
Swapnil Mahajan
RVRandi Vita
Randi Vita
ZKZeynep Kosaloglu-Yalcin
Zeynep Kosaloglu-Yalcin
BPBjoern Peters
Bjoern Peters
The adaptive immune system in vertebrates has evolved to recognize non-self-antigens, such as proteins expressed by infectious agents and mutated cancer cells. T cells play an important role in antigen recognition by expressing a diverse repertoire of antigen-specific receptors, which bind epitopes to mount targeted immune responses. Recent advances in high-throughput sequencing have enabled the routine generation of T-cell receptor (TCR) repertoire data. Identifying the specific epitopes targeted by different TCRs in these data would be valuable. To accomplish that, we took advantage of the ever-increasing number of TCRs with known epitope specificity curated in the Immune Epitope Database (IEDB) since 2004. We compared six metrics of sequence similarity to determine their power to predict if two TCRs have the same epitope specificity. We found that a comprehensive k -mer matching approach produced the best results, which we have implemented into TCRMatch, an openly accessible tool ( http://tools.iedb.org/tcrmatch/ ) that takes TCR β-chain CDR3 sequences as an input, identifies TCRs with a match in the IEDB, and reports the specificity of each match. We anticipate that this tool will provide new insights into T cell responses captured in receptor repertoire and single cell sequencing experiments and will facilitate the development of new strategies for monitoring and treatment of infectious, allergic, and autoimmune diseases, as well as cancer.